Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2025Journal of Controlled ReleaseOpen Access

Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity

View Full Paper
Ask AI
Bookmark
Share

Authors

YSYing SunJSJialin SunQGQie Guo

Discussion

Loading...

Member takes

Overview

Innovative dendritic cell vaccine improves therapeutic efficacy and reduces metastasis in postoperative cancer treatment, indicating potential benefits of enhanced T cell interaction.

Key Points

  • This research aims to develop a more effective dendritic cell vaccine that enhances antitumor immunity by improving T cell contact and activation.
  • Development of a potent DC vaccine using nanoscale antigen delivery and synthetic immunological approaches.
  • Administration via subcutaneous injection in the inguinal region.
  • Evaluation of immune response and efficacy in postoperative tumor models in mice.
  • The vaccine activated cellular immunity by effectively cross-presenting tumor antigens.
  • Significant therapeutic efficacy was noted in inhibiting tumor cell recurrence and metastasis.
  • Combining the vaccine with PD-1 antibody therapy further prolonged survival duration in treated mice.

Cite This Study

Sun et al. (2025) studied this question.

synapsesocial.com/papers/6924f07ac0ce034ddc34fed3https://doi.org/10.1016/j.jconrel.2025.114429
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies2024 · 10 citations
  2. 2Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges2026 · 3 citations
  3. 3Redefining Dendritic Cell Vaccines: Synergistically Co‐priming DC and B Cells With Nanoparticles Loading Whole Cell Antigens Maximizes the Efficacy of DC Vaccines2026 · 2 citations
  4. 4Antigen Self-Presented Personalized Nanovaccines Boost the Immunotherapy of Highly Invasive and Metastatic Tumors2024 · 36 citations
  5. 5Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity2026